Share capital

Travis Perkins: Total Voting Rights

Retrieved on: 
Monday, January 4, 2021

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Kiadis issues “holdback” shares to former Cytosen shareholders

Retrieved on: 
Monday, December 7, 2020

The Company will today issue 267,012 ordinary shares of Kiadis stock with a nominal value of 0.10 to former CytoSen Therapeutics Inc. (CytoSen) shareholders pursuant to the agreement made in relation to the Companys acquisition of CytoSen in June 2019.

Key Points: 
  • The Company will today issue 267,012 ordinary shares of Kiadis stock with a nominal value of 0.10 to former CytoSen Therapeutics Inc. (CytoSen) shareholders pursuant to the agreement made in relation to the Companys acquisition of CytoSen in June 2019.
  • As this period now ceased, Kiadis will issue the related number of shares to the former CytoSen shareholders today.
  • The ordinary shares issued to the former CytoSen shareholders listed below represent 0.0066% of the issued and outstanding shares in the capital of Kiadis.
  • The former CytoSen shareholders who will be issued holdback shares are as follows:

Travis Perkins: Total Voting Rights

Retrieved on: 
Tuesday, December 1, 2020

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Travis Perkins: Total Voting Rights

Retrieved on: 
Monday, November 2, 2020

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

DGAP-News: Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price

Retrieved on: 
Thursday, October 29, 2020

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax said: "We are very happy with the successful completion of Abivax's capital increase of EUR 28m which will contribute to achieve a number of important value-creating milestones.

Key Points: 
  • Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax said: "We are very happy with the successful completion of Abivax's capital increase of EUR 28m which will contribute to achieve a number of important value-creating milestones.
  • Didier Blondel, CFO of Abivax, added: "Given the current market conditions, the capital increase of EUR 28m is a great success for the Company as well as for our existing shareholders as it was oversubscribed at market price with a limited dilution of 11.70%.
  • After the Capital Increase, Sofinnova will continue to hold 12.26% of the share capital of the Company.
  • For illustration purposes, a shareholder holding 1% of the Company's share capital prior to the Capital Increase, will hold 0.88% of the Company's share capital upon completion of the Capital Increase (or 0.75% on a fully diluted basis).

AEW UK REIT plc: Transaction in own shares

Retrieved on: 
Wednesday, October 14, 2020

The Company announces that on 14 October 2020 it purchased 200,000 Ordinary Shares of 1p each in the capital of the Company at a price of 76.5p per Ordinary Share.

Key Points: 
  • The Company announces that on 14 October 2020 it purchased 200,000 Ordinary Shares of 1p each in the capital of the Company at a price of 76.5p per Ordinary Share.
  • Following the transaction, the Company's issued share capital is 158,774,746 Ordinary Shares.
  • The Company holds 200,000 Ordinary Shares in treasury, which do not carry any voting rights.
  • Accordingly, the total number of voting rights in the Company is 158,574,746 Ordinary Shares.

Smart Eye has completed a directed share issue of SEK 189 million

Retrieved on: 
Monday, October 5, 2020

Today's issue of SEK 189 million ensures our ability to deliver to the many won global automotive projects while strengthening our competitiveness ahead of the coming wave of new procurements.

Key Points: 
  • Today's issue of SEK 189 million ensures our ability to deliver to the many won global automotive projects while strengthening our competitiveness ahead of the coming wave of new procurements.
  • Using eye tracking to save lives is nowadays a given in the automotive industry," says Martin Krantz, CEO of Smart Eye.
  • The Issue entails a dilution of approximately 9.1 per cent of the share capital in relation to the number of shares in Smart Eye after the Issue, through an increase in the number of outstanding shares by 1,511,898 from 15,118,984 to 16,630,882and a share capital increase by SEK 151,189.8 from SEK 1,511,898.4 to SEK 1,663,088.2.
  • This is information that Smart Eye AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

Smart Eye has completed a directed share issue of SEK 189 million

Retrieved on: 
Monday, October 5, 2020

Today's issue of SEK 189 million ensures our ability to deliver to the many won global automotive projects while strengthening our competitiveness ahead of the coming wave of new procurements.

Key Points: 
  • Today's issue of SEK 189 million ensures our ability to deliver to the many won global automotive projects while strengthening our competitiveness ahead of the coming wave of new procurements.
  • Using eye tracking to save lives is nowadays a given in the automotive industry," says Martin Krantz, CEO of Smart Eye.
  • The Issue entails a dilution of approximately 9.1 per cent of the share capital in relation to the number of shares in Smart Eye after the Issue, through an increase in the number of outstanding shares by 1,511,898 from 15,118,984 to 16,630,882and a share capital increase by SEK 151,189.8 from SEK 1,511,898.4 to SEK 1,663,088.2.
  • This is information that Smart Eye AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

Travis Perkins: Total Voting Rights

Retrieved on: 
Thursday, October 1, 2020

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • In conformity with DTR5.6.1R, the Company notifies the market of the following:
    As at the date of this announcement, the Company's issued share capital consists of 252,143,923 ordinary shares with a nominal value of 10 pence each ("Ordinary Shares"), with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares with voting rights is 252,143,923.

Total Voting Rights

Retrieved on: 
Thursday, October 1, 2020

Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold mining and development company, announces, for the purposes of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the following:

Key Points: 
  • Serabi Gold plc (AIM:SRB, TSX:SBI), the Brazilian focused gold mining and development company, announces, for the purposes of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the following:
    As at the date of this announcement, the Company's issued share capital consists of 59,084,551 Ordinary Shares with a nominal value of 10.0p each, with voting rights.
  • The Company does not hold any Ordinary Shares in Treasury.
  • Therefore, the total number of Ordinary Shares in the Company with voting rights is 59,084,551.
  • The above figure of 59,084,551 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authoritys Disclosure Guidance and Transparency Rules.